Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
As of close of business last night, Impact BioMedical Inc’s stock clocked out at $0.61, up 1.63% from its previous closing price of $0.60. In other words, the price has increased by $1.63 from its previous closing price. On the day, 2.48 million shares were traded.
Ratios:
To gain a deeper understanding of IBO’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.25 and its Current Ratio is at 0.25. In the meantime, Its Debt-to-Equity ratio is 2.08 whereas as Long-Term Debt/Eq ratio is at 0.00.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Apr 04 ’25 when DSS, INC. sold 890,800 shares for $0.95 per share. The transaction valued at 845,013 led to the insider holds 161,100 shares of the business.
Chan Heng Fai Ambrose sold 351,555 shares of IBO for $174,020 on Apr 03 ’25. The Director now owns 0 shares after completing the transaction at $0.49 per share. On Apr 02 ’25, another insider, Chan Heng Fai Ambrose, who serves as the Director of the company, sold 884,776 shares for $0.60 each. As a result, the insider received 533,636 and left with 351,555 shares of the company.
Stock Price History:
Over the past 52 weeks, IBO has reached a high of $6.17, while it has fallen to a 52-week low of $0.37. The 50-Day Moving Average of the stock is -42.12%, while the 200-Day Moving Average is calculated to be -64.65%.
Shares Statistics:
A total of 11.50M shares are outstanding, with a floating share count of 10.07M. Insiders hold about 12.50% of the company’s shares, while institutions hold 0.93% stake in the company.
Earnings Estimates
The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between $0 and $0 for the fiscal current year, implying an average EPS of $0.
